Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34 Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 316K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 18K
20: R1 Document And Entity Information HTML 42K
42: R2 Consolidated Balance Sheets HTML 116K
48: R3 Consolidated Balance Sheets (Parenthetical) HTML 32K
30: R4 Consolidated Statements Of Operations HTML 78K
19: R5 Consolidated Statements Of Shareholders' Equity HTML 39K
and Comprehensive Loss
40: R6 Consolidated Statements Of Cash Flows HTML 100K
47: R7 Organization and Description of Business HTML 22K
31: R8 Going concern (Notes) HTML 22K
18: R9 Significant Accounting Policies HTML 106K
26: R10 Discontinued operation (Notes) HTML 56K
14: R11 Related Party Transactions HTML 27K
38: R12 Line of credit (Notes) HTML 23K
46: R13 Concentration of credit risk (Notes) HTML 36K
25: R14 Retirement and post retirement plans (Notes) HTML 22K
13: R15 Significant Accounting Policies (Policies) HTML 201K
37: R16 Leases (Policies) HTML 82K
45: R17 Significant Accounting Policies (Tables) HTML 82K
27: R18 Concentration of credit risk (Tables) HTML 39K
12: R19 Retirement and post retirement plans (Tables) HTML 19K
34: R20 Inventories (Tables) HTML 39K
50: R21 Leases (Tables) HTML 122K
24: R22 Going concern (Details) HTML 19K
22: R23 Significant Accounting Policies (Cash and Cash HTML 21K
Equivalents) (Details)
33: R24 Significant Accounting Policies (Inventory) HTML 28K
(Details)
49: R25 Significant Accounting Policies (Accounts HTML 18K
Receivable) (Details)
23: R26 Significant Accounting Policies (Net Income (loss) HTML 30K
Per Share) (Details)
21: R27 Significant Accounting Policies Earning per share HTML 61K
details (Details)
32: R28 Significant Accounting Policies Goodwill and HTML 18K
intangible assets (Details)
51: R29 Significant Accounting Policies deferred revenue HTML 22K
(Details)
43: R30 Discontinued operation (Details) HTML 37K
35: R31 Related Party Transactions (Details) HTML 45K
15: R32 Line of credit (Details) HTML 53K
28: R33 Concentration of credit risk (Details) HTML 74K
44: R34 Revenue from contracts with customers (Details) HTML 22K
36: R35 Retirement and post retirement plans (Details) HTML 31K
16: R36 Leases (Details) HTML 62K
17: R9999 Uncategorized Items - esmc-20190930.xml HTML 20K
41: XML IDEA XML File -- Filing Summary XML 85K
29: EXCEL IDEA Workbook of Financial Reports XLSX 51K
6: EX-101.INS XBRL Instance -- esmc-20190930 XML 872K
8: EX-101.CAL XBRL Calculations -- esmc-20190930_cal XML 122K
9: EX-101.DEF XBRL Definitions -- esmc-20190930_def XML 398K
10: EX-101.LAB XBRL Labels -- esmc-20190930_lab XML 948K
11: EX-101.PRE XBRL Presentations -- esmc-20190930_pre XML 578K
7: EX-101.SCH XBRL Schema -- esmc-20190930 XSD 87K
39: ZIP XBRL Zipped Folder -- 0000862668-19-000017-xbrl Zip 129K
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Richard J. DePiano Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.
The
Quarterly Report of Escalon Medical Corp. on Form 10Q for the quarterly period ended September 30, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
